Intravesical hyperthermic chemotherapy with mitomycin C in patients with non-muscle-invasive bladder cancer, initial experience in a single center

Kostev, F. I.; Chystiakov, R. S.; Lysenko, V. V.; Stavnychyi, O. S.; Rosha, L. G.

dc.contributor.author	Kostev, F. I.	en
dc.contributor.author	Chystiakov, R. S.	en
dc.contributor.author	Lysenko, V. V.	en
dc.contributor.author	Stavnychyi, O. S.	en
dc.contributor.author	Rosha, L. G.	en
dc.date.accessioned	2021-11-18T10:29:45Z
dc.date.available	2021-11-18T10:29:45Z
dc.date.issued	2019
dc.identifier.citation	Intravesical hyperthermic chemotherapy with mitomycin C in patients with non-muscle-invasive bladder cancer, initial experience in a single center / F. I. Kostev, R. S. Chystiakov, V. V. Lysenko et al // Досягнення і перспективи в онкоурології, пластичній та реконструктивній хірургії сечовивідних шляхів: VIII Міжнар. конгрес спілки онкоурологів України СОУУ – 2019, 11–13 квітня 2019 р., м. Київ: матер. – Київ, 2019. – С. 78.	en
dc.identifier.uri	https://repo.odmu.edu.ua:443/xmlui/handle/123456789/10391
dc.description.abstract	The EUA 2018 guidelines recommend that patients with high-risk NMIBC receive either intravesical BCG or radical cystectomy. BCG therapy is difficult to tolerate by patients and some patients are not suitable for cystectomy. The hyperthermic intravesical chemotherapy (HIVEC) can be an alternative method for this category of patients, and a large number of studies currently underway confirms this. HIVEC is presented in EAU Guidelines 2018 for non-muscle-invasive bladder cancer. We present the early results of our series in patients treated with COMBAT BRS-HIVEC recirculation system. Objective. To study the efficacy and safety of adjuvant treatment of patients with non-muscleinvasive bladder cancer by using the method of hyperthermic intravesical chemotherapy of the bladder in adjuvant mode.	en
dc.language.iso	en	en
dc.subject	intravesical hyperthermic chemotherapy	en
dc.subject	mitomycin C	en
dc.subject	non-muscle-invasive bladder cancer	en
dc.subject	adjuvant treatment	en
dc.title	Intravesical hyperthermic chemotherapy with mitomycin C in patients with non-muscle-invasive bladder cancer, initial experience in a single center	en
dc.type	Article	en